🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Following acute COVID-19, some patients develop a group of debilitating sym...
Status
Completed
Location
Bateman Horne Center
Start Date
2023-06-01
Trial ID
NCT05840237
Treatments Being Tested
There is no approved treatment for fatigue in Myalgic Encephalomyelitis/Chr...
Status
Completed
Location
Bateman Horne Center
Start Date
2022-03-15
Trial ID
NCT05273372
Treatments Being Tested
This phase I trial studies the impact of taking drugs (agents) that target ...
Status
Withdrawn
Location
Mayo Clinic in Rochester
Start Date
2025-10-20
Trial ID
NCT05720624
The purpose of this study is to determine if oxaloacetate (OAA) is safe and...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2015-10
Trial ID
NCT02593318
Treatments Being Tested
The purpose of this study is to determine the safety and the maximal tolera...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2020-03-17
Trial ID
NCT04204889
Treatments Being Tested
This is a phase 1 clinical trial studying whether or not oxaloacetate has a...
Status
Withdrawn
Location
University of Kansas Medical Center
Start Date
2025-08
Trial ID
NCT04965987
Treatments Being Tested
By doing this study, researchers hope to learn how much oxaloacetate (OAA) ...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2014-02
Trial ID
NCT02063308
Treatments Being Tested
The purpose of this study is to determine if Oxaloacetate (OAA) is a safe a...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2012-12
Trial ID
NCT01741701
Treatments Being Tested